|
NVST
|
Envista Holdings Corporation
|
0.10%
|
US
|
NYSE
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
EXEL
|
Exelixis, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
BRKR
|
Bruker Corporation
|
0.10%
|
US
|
NASDAQ
|
|
TDOC
|
Teladoc, Inc.
|
0.09%
|
US
|
NYSE
|
|
PRGO
|
Perrigo Company
|
0.09%
|
US
|
NYSE
|
|
NVCR
|
NovoCure Limited
|
0.09%
|
US
|
NASDAQ
|
|
QDEL
|
Quidel Corporation
|
0.08%
|
US
|
NASDAQ
|
|
LHCG
|
LHC Group
|
0.08%
|
US
|
NASDAQ
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
0.08%
|
US
|
NASDAQ
|
|
AZTA
|
Azenta, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
PEN
|
Penumbra, Inc.
|
0.08%
|
US
|
NYSE
|
|
HQY
|
HealthEquity, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
DVA
|
DaVita HealthCare Partners Inc.
|
0.08%
|
US
|
NYSE
|
|
GH
|
Guardant Health, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
PINC
|
Premier, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
OMCL
|
Omnicell, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
NVAX
|
Novavax, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
0.07%
|
US
|
NASDAQ
|